Cash Flow from Operating Activities: A company's cash flows from operations.
Acumen Pharmaceuticals, Inc. (ABOS) had Cash Flow from Operating Activities of $-96.44M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-26.45M |
|
-- |
|
-- |
|
$26.51M |
|
$-26.51M |
|
$0.06M |
|
$-26.45M |
|
$-26.45M |
|
$-26.45M |
|
$-26.45M |
|
$-26.45M |
|
$-26.45M |
|
$-26.51M |
|
$-26.74M |
|
60.57M |
|
60.57M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$132.15M |
|
-- |
|
$10.07M |
|
$142.22M |
|
$21.96M |
|
$27.05M |
|
$27.09M |
|
$49.05M |
|
$93.17M |
|
$93.17M |
|
$93.17M |
|
60.57M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-96.44M |
$107.68M |
|
$-0.04M |
|
$35.86M |
|
$47.06M |
|
$11.21M |
|
$7.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.02 |
|
-- |
|
-- |
|
0.23 |
|
0.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-96.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.39% |
|
-28.39% |
|
-18.60% |
|
-22.00% |
|
$1.54 |
|
$-1.59 |
|
$-1.59 |
|